MUC16 (CA125): tumor biomarker to cancer therapy, a work in progressMildred Felder, Manish S. Patankar, Arvinder Kapur et al.|Molecular Cancer|2014Cited by 559
Pulse methotrexate versus pulse actinomycin D in the treatment of low‐risk gestational trophoblastic neoplasiaFariba Yarandi, Parviz Hanjani, Zahra Eftekhar et al.|International Journal of Gynecology & Obstetrics|2008Cited by 68
Efficacy of Megestrol Acetate (Megace) in the Treatment of Patients With Early Endometrial Adenocarcinoma: Our Experiences With 21 PatientsZahra Eftekhar, Narges Izadi‐Mood, Fariba Yarandi et al.|International Journal of Gynecological Cancer|2009Cited by 65
Chronic Pain after Spinal Cord Injury: Results of a Long-Term StudyEhsan Modirian, HamidReza Zamani, Pirouz Pirouzi et al.|Pain Medicine|2010Cited by 56
Comparison of pulsed actinomycin D versus 5‐day methotrexate for the treatment of low‐risk gestational trophoblastic diseaseAzamsadat Mousavi, Hadi Shojaei, Fatemeh Cheraghi et al.|International Journal of Gynecology & Obstetrics|2011Cited by 51